The lives of Americans could be dramatically improved, and in thousands of cases even saved, by increasing access to ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...

The diabetes and weight loss drug Ozempic could lower the risk of Alzheimer’s disease among people with type 2 diabetes, ...

New study questions benefits of GLP-1 drugs for weight loss, finding high costs with little long-term health benefit. Read ...

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...

The UK's drug safety regulator is asking doctors to be alert for patients who may be misusing obesity injections, such as ...

Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.

Some adults are seeing results in losing weight or reducing their risk of diabetes and heart disease using injectables, such ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic ...

A common diabetes and weight-loss drug may also reduce the risk of Alzheimer’s disease, according to a new study. American ...